Document is current
Any future updates will be listed below
-
Authors
Thongsa-ad, Umnuaychoke
Wongpan, Anongnat
Wongkummool, Wasinee
Chaiwijit, Phaewa
Uppakara, Kwanchanok
Chaiyakitpattana, Gorawin
Singpant, Passanan
Tong-ngam, Pirut
Chukhan, Amnat
Pabuprappap, Wachirachai
Wongniam, Sirapope
Suksamrarn, Apichart
Hongeng, Suradej
Anurathapan, Usanarat
Kulkeaw, Kasem
Tubsuwan, Alisa
Bhukhai, Kanit
-
Funding
Funding for this research was provided by:
Mahidol University (MU’s Strategic Research Fund: fiscal year 2023)
National Research Council of Thailand (N41A660154)
Ministry of Science and Technology of Thailand (the Science Achievement Scholarship of Thailand)
Ramathibodi Foundation
Faculty of Science, Mahidol University (the Central Instrument Facility (CIF))
Mahidol University
- License Information
-
More Information
Article History
Received: 4 July 2023
Accepted: 27 February 2024
First Online: 3 March 2024
Declarations
:
: Donor-informed consent for human iPSC-related experiments was approved by the Mahidol University Central Institutional Review Board (COE No. MU-CIRB 2022/161.1711), title of the approved project: Development of Human Induced Pluripotent Stem Cell-Based Platforms for Hematopoietic Stem Cells Generation, date of approval: 17 November 2022. Human Research Ethics Committee, Faculty of Medicine Ramathibodi Hospital, Mahidol University has approved the human umbilical cord blood (UCB)-related experiment at Ramathibodi Hospital (COA. MURA 2022/65), title of the approved project: Application of umbilical cord blood-derived hematopoietic stem cells for hematological disorder treatment, date of approval: 24 January 2022. National Blood Centre, Thai Red Cross Society (COA No. NBC 6/2022), title of the approved project: Application of umbilical cord blood-derived hematopoietic stem cells for hematological disorder treatment, date of approval: 27 Apr 2022. The protocols used in this study were processed following the Helsinki Declaration. All donors signed a participant information sheet and informed consent before sampling.
: Not applicable.
: AC is a consultant and an employee of Prima Scientific, and he declares potential competing interests. The other authors declare that they have no competing interests.
